You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alpelisib

Showing 26 - 47 of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PIK3CA-related Overgrowth Spectrum (PROS) Trial in Worldwide (Alpelisib, Placebo)

Recruiting
  • PIK3CA-related Overgrowth Spectrum (PROS)
  • Alpelisib
  • Placebo
  • Los Angeles, California
  • +38 more
Nov 25, 2022

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Alpelisib, Tamoxifen, Infigratinib)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Alpelisib
  • +3 more
  • Stanford, California
    Stanford University
Nov 16, 2022

Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

Not yet recruiting
  • Slow-Flow Vascular Malformation
  • +17 more
  • Parkville, Victoria, Australia
    The Royal Children's Hospital
Aug 7, 2023

Breast Cancer Trial in Spain (Alpelisib, Metformin, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Alpelisib
  • +4 more
  • Alicante, Spain
  • +17 more
Aug 23, 2022

Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Aug 12, 2022

Advanced HER2+Breast Cancer Trial in Worldwide (Alpelisib, Alpelisib matching Placebo, Trastuzumab)

Active, not recruiting
  • Advanced HER2+Breast Cancer
  • Alpelisib
  • +3 more
  • Fayetteville, Arkansas
  • +98 more
Dec 16, 2022

Hepatic Impairment Trial in United States (Alpelisib)

Completed
  • Hepatic Impairment
  • Alpelisib
  • Lakewood, Colorado
  • +3 more
Dec 6, 2020

Breast Cancer Trial in Italy (Ribociclib, Letrozole, Alpelisib)

Active, not recruiting
  • Breast Cancer
  • Casale Monferrato, AL, Italy
  • +40 more
Dec 3, 2021

Advanced Breast Cancer Trial in Worldwide (Trastuzumab, Alpelisib, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Trastuzumab
  • +5 more
  • Graz, Austria
  • +107 more
Aug 8, 2022

Breast Cancer Trial in Worldwide (Alpelisib, Fulvestrant, Letrozole)

Active, not recruiting
  • Breast Cancer
  • Alpelisib
  • +4 more
  • Gilbert, Arizona
  • +93 more
Nov 10, 2022

Triple Negative Breast Tumors Trial in Worldwide (alpelisib, , nab-paclitaxel)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • alpelisib
  • +2 more
  • Los Alamitos, California
  • +154 more
Jan 12, 2023

Ovarian Cancer Trial in Worldwide (Alpelisib, Olaparib, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • Alpelisib
  • +3 more
  • Phoenix, Arizona
  • +116 more
Nov 25, 2022

Tumors, Breast Tumors, Kidney Tumors Trial in Worldwide (alpelisib, everolimus, exemestane)

Completed
  • Neoplasms
  • +3 more
  • alpelisib
  • +2 more
  • Fayetteville, Arkansas
  • +21 more
Dec 4, 2020

Meningioma Trial in Marseille (drug, biological, device)

Recruiting
  • Meningioma
  • Marseille, France
    Assistance Publique Hôpitaux de Marseille
Apr 29, 2020

Breast Cancer Trial in Worldwide (Amcenestrant, Palbociclib, Alpelisib)

Active, not recruiting
  • Breast Cancer
  • Denver, Colorado
  • +30 more
Aug 18, 2022

Sequence in HR+, HER2 - mBC in Moscow: A Multicenter

Recruiting
  • Breast Cancer Stage IV
  • Moscow, Russian Federation
    N.N. Blokhin National Medical Research Center of Oncology
Apr 15, 2021

Solid Tumors Trial in San Francisco (Alpelisib, Cisplatin)

Terminated
  • Solid Tumors
  • San Francisco, California
    UCSF Helen Diller Family Comprehensive Cancer Center
Jan 7, 2020

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Unknown status
  • Anatomic Stage I Breast Cancer AJCC v8
  • +21 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 11, 2020

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (LY3484356, Abemaciclib, Everolimus)

Recruiting
  • Breast Cancer
  • +3 more
  • Gilbert, Arizona
  • +76 more
Jan 27, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Breast Cancer Trial in Worldwide (alpelisib, buparlisib, Placebo)

Completed
Has Results
  • Breast Cancer
  • alpelisib
  • +2 more
  • Birmingham, Alabama
  • +86 more
Aug 13, 2018